March 13, 2020 / 6:07 AM / 22 days ago

BRIEF-UCB Updates On Phase 2B Padsevonil Safety And Efficacy Study In Epilepsy

March 13 (Reuters) - Ucb SA:

* UCB PROVIDES AN UPDATE ON PHASE 2B PADSEVONIL SAFETY AND EFFICACY STUDY IN EPILEPSY (ARISE)

* ARISE DID NOT REACH STATISTICAL SIGNIFICANCE FOR EITHER OF TWO PRIMARY ENDPOINTS

* UCB WILL FURTHER ANALYSE DATA TO BETTER UNDERSTAND RESULTS AND THEIR IMPLICATIONS Source text : bit.ly/3cS0hQ9 Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below